Microneedle array patches (MAPs) have the potential to transform delivery of medications and vaccines. While this innovative drug delivery format could result in improved efficiency across a wide range of therapeutics, it also brings critical challenges. To successfully move from concept to commercialization, MAP manufacturers must consider scalability, regulatory compliance, and other complexities. In this webinar, our experts address these considerations and share their expertise.
Download the webinar recording to discover:
- The advantages of different kinds of MAPs
- Methods for patch characterization across analytical, performance, and preclinical assessments, and how these help ensure safety and efficacy
- Techniques to evaluate critical performance factors of microneedle patches, such as skin penetration and delivery efficiency
- The benefits of optimized product evaluation to accelerate development and minimize risks
Download the Webinar
Fields marked with an * are required.